Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
2.960
+0.230 (8.42%)
At close: Aug 21, 2026, 4:00 PM EDT
2.890
-0.070 (-2.36%)
After-hours: Aug 21, 2026, 7:59 PM EDT
Femasys Employees
As of December 31, 2025, Femasys had 54 total employees, including 51 full-time and 3 part-time employees. The number of employees decreased by 17 or -23.94% compared to the previous year.
Employees
54
Change (1Y)
-17
Growth (1Y)
-23.94%
Revenue / Employee
$42,583
Profits / Employee
-$217,928
Market Cap
24.79M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 54 | -17 | -23.94% | 51 | 3 |
| Dec 31, 2024 | 71 | 37 | 108.82% | 69 | 2 |
| Dec 31, 2023 | 34 | -2 | -5.56% | 32 | 2 |
| Dec 31, 2022 | 36 | 7 | 24.14% | 34 | 2 |
| Dec 31, 2021 | 29 | 3 | 11.54% | 27 | 2 |
| Jun 30, 2021 | 27 | - | - | 25 | 2 |
| Mar 31, 2021 | 26 | - | - | 24 | 2 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Harvard Bioscience | 339 |
| Jin Medical International | 273 |
| Retractable Technologies | 201 |
| Bionano Genomics | 97 |
| Precision Optics Corporation | 90 |
| Nephros | 36 |
| NEXGEL | 19 |
| Milestone Scientific | 15 |
FEMY News
- 4 days ago - Femasys announces FDA approval of FemBloc modular premarket approval application - TheFly
- 5 days ago - Femasys price target lowered to $10 from $30 at Lake Street - TheFly
- 6 days ago - Femasys issued patent for FemBloc blended polymer component - TheFly
- 7 days ago - Femasys price target lowered to $10 from $30 at Maxim - TheFly
- 8 days ago - Femasys Announces Financial Results for Quarter Ended June 30, 2026 and Provides Corporate Update - GlobeNewsWire
- 9 days ago - Femasys Earnings release: Q2 2026 - Filings
- 9 days ago - Femasys Quarterly report: Q2 2026 - Filings
- 11 days ago - Femasys Strengthens and Extends Global Patent Protection for FemBloc® with First Issued Blended Polymer Patents - GlobeNewsWire